Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
When tirzepatide (Mounjaro) was first approved by the FDA in May 2022 for type 2 diabetes, it received the standard 5 years of market exclusivity as a new chemical entity (NCE)
Transdermal drug delivery
Thus, it would provide a safer and more effective treatment option for cardiomyopathy patients
The two companies are currently fighting for market share in the type 2 diabetes (T2D) and weight loss markets, with sales of Nordisk's Ozempic and Wegovy slowing due to competition from Lilly's Zepbound and Mounjaro (tirzepatide), which brought in $8.57bn in Q2.
Hypoallergenic Gluten-Free Non-GMO Vegan Vegetarian Made in USA * These statements have not been evaluated by the Food & Drug Administration
Tap the syringe with the needle pointing up to float bubbles to the top, then push the plunger gently to expel them before reading your volume
